Software to reduce motion-related errors in MRI scans
Framewise Integrated Real-Time MRI Monitoring (FIRMM) software commercialization readiness for clinical care
This study is working on new software that helps make MRI scans clearer by reducing blurriness caused by patient movement, so that doctors can get better and more accurate images for diagnosing health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Turing Medical Technologies INC NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11047750 on NIH RePORTER |
What this research studies
This research focuses on improving MRI imaging by developing software that minimizes errors caused by patient movement during scans. The Framewise Integrated Real-Time MRI Monitoring (FIRMM) software aims to enhance the quality of MRI images, which can be compromised by motion artifacts. By partnering with Siemens, the project seeks to integrate FIRMM into clinical workflows, making it easier for healthcare providers to use this technology effectively. The goal is to ensure that patients receive clearer and more accurate MRI results, ultimately improving diagnostic capabilities.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing MRI scans who may be at risk of motion-related artifacts due to discomfort or inability to remain still.
Not a fit: Patients who do not require MRI imaging or those who can remain perfectly still during scans may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate MRI scans, reducing the need for repeat imaging and improving patient outcomes.
How similar studies have performed: Previous research has shown success in using technology to reduce motion artifacts in imaging, indicating a promising potential for this approach.
Where this research is happening
Saint Louis, United States
- Turing Medical Technologies INC — Saint Louis, United States (Active)
Researchers
- Principal investigator: King, Kevin — Turing Medical Technologies INC
- Study coordinator: King, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.